Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.63 USD | -0.17% | -0.21% | -21.15% |
Financials (USD)
Sales 2024 * | 29.54M | Sales 2025 * | 186M | Capitalization | 2.14B |
---|---|---|---|---|---|
Net income 2024 * | -262M | Net income 2025 * | -217M | EV / Sales 2024 * | 66.9 x |
Net cash position 2024 * | 163M | Net cash position 2025 * | 59.29M | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
-8.89
x | P/E ratio 2025 * |
-12.6
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.43% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -0.17% | ||
1 week | -0.21% | ||
Current month | -12.29% | ||
1 month | -13.16% | ||
3 months | -15.15% | ||
6 months | +32.38% | ||
Current year | -21.15% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 23.63 | -0.17% | 918,654 |
24-04-23 | 23.67 | -0.84% | 451,559 |
24-04-22 | 23.87 | +4.69% | 570,571 |
24-04-19 | 22.8 | -2.90% | 960,831 |
24-04-18 | 23.48 | -0.84% | 551,369 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.15% | 2.14B | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- RCKT Stock